Drug Type Small molecule drug |
Synonyms Compound 3r(Yonsei University) |
Target |
Mechanism PLD1 inhibitors(phospholipase D1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | KR | 15 Oct 2024 |